86 related articles for article (PubMed ID: 16555005)
1. The Tre2 oncoprotein, implicated in Ewing's sarcoma, interacts with two components of the cytoskeleton.
Dechamps C; Bach S; Portetelle D; Vandenbol M
Biotechnol Lett; 2006 Feb; 28(4):223-31. PubMed ID: 16555005
[TBL] [Abstract][Full Text] [Related]
2. Expression in a RabGAP yeast mutant of two human homologues, one of which is an oncogene.
Bizimungu C; De Neve N; Burny A; Bach S; Bontemps F; Portetelle D; Vandenbol M
Biochem Biophys Res Commun; 2003 Oct; 310(2):498-504. PubMed ID: 14521938
[TBL] [Abstract][Full Text] [Related]
3. At least two regions of the oncoprotein Tre2 are involved in its lack of GAP activity.
Bizimungu C; Vandenbol M
Biochem Biophys Res Commun; 2005 Sep; 335(3):883-90. PubMed ID: 16099424
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the TRE2 oncogene encoding an inactive RabGAP.
Bizimungu C; Thomas A; Brasseur R; Vandenbol M
Biotechnol Lett; 2007 Dec; 29(12):1927-37. PubMed ID: 17701273
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor expression is up-regulated by EWS-ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing's sarcoma.
Fuchs B; Inwards CY; Janknecht R
Clin Cancer Res; 2004 Feb; 10(4):1344-53. PubMed ID: 14977835
[TBL] [Abstract][Full Text] [Related]
6. Ezrin mediates growth and survival in Ewing's sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway.
Krishnan K; Bruce B; Hewitt S; Thomas D; Khanna C; Helman LJ
Clin Exp Metastasis; 2006; 23(3-4):227-36. PubMed ID: 17028919
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
[TBL] [Abstract][Full Text] [Related]
8. A polypeptide from the junction region sequence of EWS-FLI1 inhibits Ewing's sarcoma cells, interacts with the EWS-FLI1 and partner proteins.
Thangaretnam KP; Gopisetty G; Ramanathan P; Rajkumar T
Sci Rep; 2017 Aug; 7(1):7172. PubMed ID: 28775288
[TBL] [Abstract][Full Text] [Related]
9. Re: Potential use of imatinib in Ewing's sarcoma: evidence for in vitro and in vivo activity.
Tamborini E; Bonadiman L; Albertini V; Pierotti MA; Pilotti S
J Natl Cancer Inst; 2003 Jul; 95(14):1087-8; author reply 1088-9. PubMed ID: 12865456
[No Abstract] [Full Text] [Related]
10. Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.
Zhang S; Guo W; Ren TT; Lu XC; Tang GQ; Zhao FL
Anticancer Drugs; 2012 Jan; 23(1):108-18. PubMed ID: 21946058
[TBL] [Abstract][Full Text] [Related]
11. Specific and sensitive detection of the EWS/FLI1 fusion protein in Ewing's sarcoma by Western blotting.
Wang M; Nilsson G; Carlberg M; Dricu A; Wejde J; Kreicbergs A; Larsson O
Virchows Arch; 1998 Feb; 432(2):131-4. PubMed ID: 9504857
[TBL] [Abstract][Full Text] [Related]
12. p53 and ras mutations in Ewing's sarcoma.
Radig K; Schneider-Stock R; Röse I; Mittler U; Oda Y; Roessner A
Pathol Res Pract; 1998; 194(3):157-62. PubMed ID: 9587933
[TBL] [Abstract][Full Text] [Related]
13. Hsp90 protein in fission yeast Swo1p and UCS protein Rng3p facilitate myosin II assembly and function.
Mishra M; D'souza VM; Chang KC; Huang Y; Balasubramanian MK
Eukaryot Cell; 2005 Mar; 4(3):567-76. PubMed ID: 15755919
[TBL] [Abstract][Full Text] [Related]
14. Interactomic approach for evaluating nucleophosmin-binding proteins as biomarkers for Ewing's sarcoma.
Haga A; Ogawara Y; Kubota D; Kitabayashi I; Murakami Y; Kondo T
Electrophoresis; 2013 Jun; 34(11):1670-8. PubMed ID: 23483572
[TBL] [Abstract][Full Text] [Related]
15. Identification of proteins interacting with protein arginine methyltransferase 8: the Ewing sarcoma (EWS) protein binds independent of its methylation state.
Pahlich S; Zakaryan RP; Gehring H
Proteins; 2008 Sep; 72(4):1125-37. PubMed ID: 18320585
[TBL] [Abstract][Full Text] [Related]
16. BLCAP induces apoptosis in human Ewing's sarcoma cells.
Fan DG; Zhao F; Ding Y; Wu MM; Fan QY; Shimizu K; Dohjima T; Nozawa S; Wakahara K; Ohno T; Guo YS; Ma BA; Jiang JL
Exp Biol Med (Maywood); 2011 Sep; 236(9):1030-5. PubMed ID: 21844121
[TBL] [Abstract][Full Text] [Related]
17. Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A.
Toretsky JA; Erkizan V; Levenson A; Abaan OD; Parvin JD; Cripe TP; Rice AM; Lee SB; Uren A
Cancer Res; 2006 Jun; 66(11):5574-81. PubMed ID: 16740692
[TBL] [Abstract][Full Text] [Related]
18. Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift.
Bridge JA; Fidler ME; Neff JR; Degenhardt J; Wang M; Walker C; Dorfman HD; Baker KS; Seemayer TA
Am J Surg Pathol; 1999 Feb; 23(2):159-65. PubMed ID: 9989842
[TBL] [Abstract][Full Text] [Related]
19. hTERT Is highly expressed in Ewing's sarcoma and activated by EWS-ETS oncoproteins.
Fuchs B; Inwards C; Scully SP; Janknecht R
Clin Orthop Relat Res; 2004 Sep; (426):64-8. PubMed ID: 15346053
[TBL] [Abstract][Full Text] [Related]
20. Potential use of imatinib in Ewing's Sarcoma: evidence for in vitro and in vivo activity.
Merchant MS; Woo CW; Mackall CL; Thiele CJ
J Natl Cancer Inst; 2002 Nov; 94(22):1673-9. PubMed ID: 12441322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]